Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum

NCT04916574 is registered in ClinicalTrials.gov with Icosagen Cell Factory as lead sponsor.

NCT NCT04916574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04916574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum
Lead sponsor
Icosagen Cell Factory
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2021
Completion date
June 3, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov2 infection